Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Consolidated Statements of Operations and Comprehensive Loss
Collaboration revenues	$ 4,896	$ 3,860
Operating expenses:
Research and development	32,211	14,284
General and administrative	14,488	16,959
Total operating expenses	46,699	31,243
Loss from operations	(41,803)	(27,383)
Other income (expense):
Interest income	2,929	218
Interest expense	(808)	(818)
Total other income (expense), net	2,121	(600)
Net loss before income tax provision	(39,682)	(27,983)
Benefit from income taxes	(618)	(419)
Net loss	$ (39,064)	$ (27,564)
Net loss per share, basic	$ (1.30)	$ (0.93)
Net loss per share, diluted	$ (1.30)	$ (0.93)
Weighted average ordinary shares outstanding, basic	30,001,725	29,605,143
Weighted average ordinary shares outstanding, diluted	30,001,725	29,605,143
Comprehensives loss:
Net loss	$ (39,064)	$ (27,564)
Other comprehensive income (loss):
Foreign currency translation adjustment	(316)	920
Total comprehensive loss	$ (39,380)	$ (26,644)